Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies

Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignanciesConcordance between <i>glucose-6-phosphate dehydrogenase</i> (<i>G6PD</i>) genotype and phenotype and rasburicase use in patients with hematologic malignancies, Published online: 12 September 2018; doi:10.1038/s41397-018-0043-3Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignancies

Source: The Pharmacogenomics Journal - September 12, 2018 Category: Drugs & Pharmacology Authors: Katherine M. Robinson Wenjian Yang Cyrine E. Haidar Jane S. Hankins Dennis W. Jay Nancy Kornegay Jeffrey E. Rubnitz Ulrich Broeckel Cheng Cheng Ching-Hon Pui Sima Jeha Mary V. Relling Source Type: research